{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-023946","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.541399+00:00","generated_at":"2026-06-14T16:07:10.721437+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Pyxis Oncology announces acquisition of Apexigen; no deal terms disclosed","bullets":["Pyxis Oncology and Apexigen held a joint investor call on May 24, 2023 to discuss the proposed business combination.","Financial terms of the acquisition were not disclosed in the filing.","The transaction is subject to customary closing conditions, including stockholder and regulatory approvals.","Pyxis plans to file a registration statement on Form S-4 in connection with the deal."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-023946","json":"https://secwatch.observer/filing/0000950170-23-023946.json","markdown":"https://secwatch.observer/filing/0000950170-23-023946.md","text":"https://secwatch.observer/filing/0000950170-23-023946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000095017023023946/0000950170-23-023946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000095017023023946/pyxs-20230524.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:07:10.721437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}